Daniela Pachito: Honored to Present Four Research Posters at ISPOR 2026
Daniela Pachito, HEOR Manager at Pfizer, shared a post on LinkedIn:
“ISPOR 2026 has come to the end. It was a fantastic conference that heavily focused on how HEOR may help shape health systems around the globe and especially on the exciting opportunities that the responsible use of AI brings to the HEOR field.
I was pleased to present four posters – one addressing AI as a tool to identify treatment patterns and resource utilization in the context of multiple myeloma in real time, which was rated among the top 5% research posters!
Also very delighted to meet old friends and to get to know – or to meet in person for the first time – some brilliant colleagues.
A special heartfelt thank you to all coauthors, including Eduardo Röcker Ramos, Marcelo Dallagassa, Alana Vicente, Celina Borges Migliavaca, Maicon Falavigna, Ashley Cha-Silva, Camilla De Gaspari, Paulo Henrique Ribeiro Fernandes Almeida, Ana Carolina Dantas, Mariana Rezende Alves, Ana Karolina Santana Nunes, among others, to Mariana Mioti Sebastião for being such a good trip companion and to Rodrigo Fernandes Alexandre and Marcio Fontão dos Reis who relentlessly incentivize evidence generation and health economics analysis as a way of leveraging access to treatments for those in need and to promote sustainability of the health system.”
Ana Karolina Santana Nunes, Manager Medical Science Liaison at Pfizer, shared a post on LinkedIn:
“Honored to have contributed as a co-author to this work presented at ISPOR 2026.
Participating in initiatives that bring together science, evidence generation, and multidisciplinary collaboration reinforces my commitment to advancing care in hemophilia and rare diseases.
I am grateful to my colleagues and co-authors for their partnership and for the opportunity to contribute to knowledge generation with the potential to impact patients and healthcare systems.”
Stay updated with Hemostasis Today.
-
Jul 20, 2026, 08:08Ifeanyichukwu Ifechidere: COVID-19 Changed Our Understanding of Coagulation
-
Jul 20, 2026, 07:27Vonwicks Czelestakov Onyango: The Anticoagulation Dilemma in Ulcerative Colitis
-
Jul 20, 2026, 06:14Elen Avetisyan: A Memorable Week of Science and Collaboration at ISTH 2026
-
Jul 19, 2026, 16:59Rupam Manna: Not All Portal Vein Involvement in HCC Is the Same
-
Jul 19, 2026, 16:58Axel Cangas: Exploring the Future of Hemophilia Care at ISTH 2026
-
Jul 19, 2026, 16:58Aviva Schwartz: Air Pollution and Women’s Hematological Health in the Spotlight at ISTH 2026
-
Jul 19, 2026, 16:56Lola Sepot-Boucherit: Reimagining the Future of Rare Bleeding Disorders at ISTH 2026
-
Jul 19, 2026, 16:54Belén de la Morena Barrio: Presenting Our Research on Long-Read Sequencing for Genetic Diagnosis at ISTH 2026
-
Jul 19, 2026, 16:52Shamee Shastry: Sometimes the Answer is Not in the Test Tube Alone, but at the Patient’s Bedside